MabCure, Inc. (MBCI)

MabCure Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007
Period Ending	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007
Revenue	0.5	-	-	-	-
Gross Profit	0.5	-	-	-	-
Selling, General & Admin	0.82	0.56	0.97	0.51	0.11
Research & Development	0.39	0.46	0.4	0	-
Operating Expenses	1.21	1.02	1.37	0.52	0.11
Operating Income	-0.71	-1.02	-1.37	-0.52	-0.11
Interest Expense	-0.19	-0.21	-0.02	-0	-
Interest & Investment Income	0	0	0	0.01	-
Other Non Operating Income (Expenses)	0.03	-	-	-0.01	-
EBT Excluding Unusual Items	-0.86	-1.23	-1.38	-0.52	-0.11
Asset Writedown	-11.4	-	-	-	-
Pretax Income	-12.26	-1.23	-1.38	-0.52	-0.11
Net Income	-12.26	-1.23	-1.38	-0.52	-0.11
Net Income to Common	-12.26	-1.23	-1.38	-0.52	-0.11
Shares Outstanding (Basic)	63	62	60	43	50
Shares Outstanding (Diluted)	63	62	60	43	50
Shares Change (YoY)	2.09%	2.81%	39.54%	-12.94%	542.17%
EPS (Basic)	-0.19	-0.02	-0.02	-0.01	-0.00
EPS (Diluted)	-0.19	-0.02	-0.02	-0.01	-0.00
Free Cash Flow	-0.06	-0.7	-1.07	-0.47	-0.09
Free Cash Flow Per Share	-0.00	-0.01	-0.02	-0.01	-0.00
Gross Margin	100.00%	-	-	-	-
Operating Margin	-141.95%	-	-	-	-
Profit Margin	-2452.97%	-	-	-	-
Free Cash Flow Margin	-12.53%	-	-	-	-
EBITDA	-0.68	-0.98	-1.33	-0.51	-
EBITDA Margin	-135.42%	-	-	-	-
D&A For EBITDA	0.03	0.04	0.04	0	-
EBIT	-0.71	-1.02	-1.37	-0.52	-0.11
EBIT Margin	-141.95%	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.